Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes for at least 12 months~* Informed consent obtained~* BMI: 6-7 years: less than or equal to 19 kg/m2, 8-9 years: less than or equal to 20 kg/m2, 10-11 years: less than or equal to 22 kg/m2, 12-13 years: less than or equal to 24 kg/m2 and 14-17 years: less than or equal to 27 kg/m2.~* HbA1c equal to or less than 12.0%~Exclusion Criteria:~* Proliferate retinopathy or maculopathy~* Total daily insulin dose greater than 2.00 IU/kg~* Any condition or disease that rule out trial participation according to the judgement of the investigator.~* Mental incapacity, unwillingness or language barriers precluding understanding or cooperation.~* A life-style incompatible with trial participation

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).